Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Equity (2024 - 2025)

Historic Return on Equity for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to 2.94%.

  • Inhibrx Biosciences' Return on Equity fell 112100.0% to 2.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.94%, marking a year-over-year decrease of 112100.0%. This contributed to the annual value of 19.06% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Inhibrx Biosciences' Return on Equity is 2.94%, which was down 112100.0% from 2.01% recorded in Q2 2025.
  • Inhibrx Biosciences' Return on Equity's 5-year high stood at 15.11% during Q1 2025, with a 5-year trough of 2.94% in Q3 2025.